We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

129 hedge funds and large institutions have $332M invested in Aerie Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 38 increasing their positions, 41 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

299% more call options, than puts

Call options by funds: $842K | Put options by funds: $211K

7% less repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 41

6% less funds holding

Funds holding: 137 → 129 (-8)

20% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 35

36% less capital invested

Capital invested by funds: $522M → $332M (-$190M)

Holders
129
Holders Change
-8
Holders Change %
-5.84%
% of All Funds
1.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
38
Reduced
41
Closed
35
Calls
$842K
Puts
$211K
Net Calls
+$631K
Net Calls Change
-$1.58M

Top Buyers

Rank Fund Capital Flow
1
JG
Jefferies Group
New York
+$24.9M
2
Morgan Stanley
Morgan Stanley
New York
+$19M
3
DM
Deerfield Management
New York
+$18M
4
Millennium Management
Millennium Management
New York
+$9.31M
5
CSS
Cubist Systematic Strategies
Connecticut
+$4.77M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$11.4M
2
William Blair Investment Management
William Blair Investment Management
Illinois
-$11.2M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$10.4M
4
ClearBridge Investments
ClearBridge Investments
New York
-$9.93M
5
Citadel Advisors
Citadel Advisors
Florida
-$6.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
ECM
51
ExodusPoint Capital Management
New York
$618K +$716K +68,388 +348%
EGM
52
Engineers Gate Manager
New York
$614K +$916K +87,521 New
Russell Investments Group
53
Russell Investments Group
United Kingdom
$593K -$48.8K -4,661 -5%
Squarepoint
54
Squarepoint
New York
$560K +$656K +62,732 +370%
Barclays
55
Barclays
United Kingdom
$553K +$369K +35,264 +81%
TIM
56
Thompson Investment Management
Wisconsin
$524K +$215K +20,500 +38%
Wells Fargo
57
Wells Fargo
California
$468K +$116K +11,125 +20%
AllianceBernstein
58
AllianceBernstein
Tennessee
$453K – – –
Jane Street
59
Jane Street
New York
$436K +$542K +51,804 +505%
California State Teachers Retirement System (CalSTRS)
60
California State Teachers Retirement System (CalSTRS)
California
$428K +$16.1K +1,534 +3%
DTL
61
Dynamic Technology Lab
Singapore
$422K +$629K +60,106 New
E
62
Ergoteles
New York
$396K +$590K +56,400 New
UBS AM
63
UBS AM
Illinois
$385K – – –
State of Wisconsin Investment Board
64
State of Wisconsin Investment Board
Wisconsin
$368K – – –
Allspring Global Investments
65
Allspring Global Investments
North Carolina
$368K +$550K +52,563 New
Tudor Investment Corp
66
Tudor Investment Corp
Connecticut
$362K -$187K -17,892 -26%
RhumbLine Advisers
67
RhumbLine Advisers
Massachusetts
$340K +$5.16K +493 +1%
PP
68
PDT Partners
New York
$284K +$423K +40,417 New
Envestnet Asset Management
69
Envestnet Asset Management
Illinois
$263K -$474K -45,292 -55%
Ensign Peak Advisors
70
Ensign Peak Advisors
Utah
$255K +$380K +36,350 New
Citadel Advisors
71
Citadel Advisors
Florida
$247K -$6.49M -620,400 -95%
Two Sigma Advisers
72
Two Sigma Advisers
New York
$247K -$2.1M -200,600 -85%
Nordea Investment Management
73
Nordea Investment Management
Sweden
$242K +$351K +33,558 New
QT
74
Quantbot Technologies
New York
$237K +$354K +33,800 New
WI
75
WrapManager Inc
California
$232K -$41.8K -3,997 -11%
1 2
3
4 5

AERI Hedge Fund Activity: Q4 2021 in Review

129 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q4 2021, worth a combined $332M — down 36% from $522M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of AERI and 28 opened new positions — a net loss of 7 holders — while 41 trimmed existing stakes and 38 added.

The largest buyer was Jefferies Group, opening a new position worth an estimated $24.9M. The largest seller was PFM Health Sciences, cutting an estimated $11.4M.

  • 129 institutional investors held Aerie Pharmaceuticals (AERI) as of Q4 2021, down from 137 in Q3 2021.
  • Funds reported $332M of Aerie Pharmaceuticals stock for Q4 2021, down 36% quarter-over-quarter.
  • 28 funds opened new Aerie Pharmaceuticals positions in Q4 2021 and 35 closed out, a net change of -7 holders.
  • The largest Aerie Pharmaceuticals buyer in Q4 2021 was Jefferies Group, an estimated $24.9M added.
  • The largest Aerie Pharmaceuticals seller in Q4 2021 was PFM Health Sciences, an estimated $11.4M sold.

Based on aggregated 13F filings for Q4 2021.